Bilirubin Blood Test Market Forecasted to Surge at a CAGR of 6.24% from 2023 to 2028 Driven by Technological Advancements and Rising Liver Disease Prevalence


Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Bilirubin Blood Test Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.

The global Bilirubin Blood Test Market is anticipated to experience significant growth, with an acceleration at a compound annual growth rate (CAGR) of 6.24%, over the next five years. An extensive report, providing a comprehensive analysis of market size, forecast, trends, growth drivers, and challenges, has been added to our suite of offerings. This analysis serves as an indispensable tool for stakeholders looking to understand the intricacies of the market.

The increasing prevalence of jaundice and liver diseases, coupled with the rise in preterm birth rates, are key factors propelling the market forward. These drivers, combined with technological improvements in bilirubin testing methods, are facilitating the adoption of bilirubin blood tests globally. The analysis delves into critical segments of the market, dissecting it by end-user, product type, and geographical landscape, thus offering detailed insights for investors and industry participants.

By segmenting the market into Infants and Adults by end-user, and further by Instruments and Consumables by product type, the report targets the core areas where bilirubin tests are most utilized. Geographically, the study covers North America, Europe, Asia, and Rest of World (ROW), recognizing the unique market dynamics and growth potential within these regions.

One of the trendsetting developments identified is the increasing demand for non-invasive bilirubin testing procedures, which is anticipated to become a significant market driver. Government initiatives and funding are also predicted to bolster market growth, particularly in the sector of bilirubin testing. Moreover, the rapid growth potential in emerging economies presents a lucrative opportunity for the bilirubin blood test market expansion.

Market Analysis and Vendor Landscape

  • Comprehensive assessment of market sizing, forecasts, and industry dynamics.
  • Identification of key market influencers and an overview of market promotions and pricing strategies.
  • Extensive research comprising both primary and secondary data sources, providing reliable, result-driven data.

The market research report includes a thorough competitive landscape that details a strategic approach to improving market position. It features an in-depth vendor selection methodology and analysis, deploying both qualitative and quantitative research to forecast accurate market growth.

This comprehensive market study on the Bilirubin Blood Test Market is essential for industry professionals, investors, and policymakers looking to capitalize on market opportunities and navigate the competitive environment effectively.

The bilirubin blood test market is segmented as below:

By End-user

  • Infants
  • Adults

By Product Type

  • Instruments
  • Consumables

Companies Profiled

  • Abbott Laboratories
  • Advanced Instruments LLC
  • ALLMEDTECH
  • AMETEK Inc.
  • Anamol Laboratories Pvt. Ltd.
  • BIOGENIX Inc. Pvt. Ltd.
  • DiaSys Diagnostic Systems GmbH
  • Dragerwerk AG and Co. KGaA
  • ELITechGroup SAS
  • F. Hoffmann La Roche Ltd.
  • GINEVRI Srl
  • Jaiprakash Associates Ltd.
  • Koninklijke Philips N.V.
  • Mega Lab SA
  • Merck KGaA
  • Micro Lab Instruments
  • Randox Laboratories Ltd.
  • Siemens AG
  • Teco Diagnostics
  • Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/n3tty3

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Coordonnées